CVS Health Corp (NYSE:CVS) EVP Eva C. Boratto sold 6,029 shares of the stock in a transaction dated Friday, March 17th. The shares were sold at an average price of $79.60, for a total transaction of $479,908.40. Following the completion of the transaction, the executive vice president now directly owns 41,614 shares of the company’s stock, valued at approximately $3,312,474.40. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.
Shares of CVS Health Corp (NYSE:CVS) traded down 0.08% during trading on Monday, hitting $78.82. 5,075,846 shares of the stock were exchanged. CVS Health Corp has a one year low of $69.30 and a one year high of $106.67. The company has a market cap of $83.63 billion, a price-to-earnings ratio of 16.06 and a beta of 0.85. The stock’s 50 day moving average price is $79.27 and its 200-day moving average price is $82.31.
CVS Health Corp (NYSE:CVS) last issued its quarterly earnings results on Thursday, February 9th. The pharmacy operator reported $1.71 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.67 by $0.04. The firm earned $46 billion during the quarter, compared to analysts’ expectations of $46.56 billion. CVS Health Corp had a net margin of 3.00% and a return on equity of 17.55%. CVS Health Corp’s quarterly revenue was up 11.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.53 EPS. On average, analysts predict that CVS Health Corp will post $5.86 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Monday, May 1st. Stockholders of record on Friday, April 21st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.54%. The ex-dividend date of this dividend is Wednesday, April 19th. CVS Health Corp’s dividend payout ratio (DPR) is presently 40.65%.
var userip;Your IP Address: document.write(userip);
Several hedge funds have recently added to or reduced their stakes in the company. Hills Bank & Trust Co. boosted its stake in CVS Health Corp by 5.3% in the third quarter. Hills Bank & Trust Co. now owns 31,595 shares of the pharmacy operator’s stock valued at $2,812,000 after buying an additional 1,580 shares during the period. Searle & CO. purchased a new stake in CVS Health Corp during the third quarter valued at approximately $2,362,000. Stillwater Capital Advisors LLC boosted its stake in CVS Health Corp by 32.6% in the third quarter. Stillwater Capital Advisors LLC now owns 115,061 shares of the pharmacy operator’s stock valued at $10,239,000 after buying an additional 28,289 shares during the period. Advisory Services Network LLC boosted its stake in CVS Health Corp by 33.9% in the third quarter. Advisory Services Network LLC now owns 14,062 shares of the pharmacy operator’s stock valued at $1,251,000 after buying an additional 3,558 shares during the period. Finally, Trust Co. of Oklahoma boosted its stake in CVS Health Corp by 5.1% in the third quarter. Trust Co. of Oklahoma now owns 44,292 shares of the pharmacy operator’s stock valued at $3,942,000 after buying an additional 2,146 shares during the period. Institutional investors own 81.29% of the company’s stock.
Several brokerages have issued reports on CVS. Leerink Swann set a $90.00 price objective on shares of CVS Health Corp and gave the stock a “buy” rating in a research note on Saturday, February 11th. Oppenheimer Holdings Inc. set a $88.00 price objective on shares of CVS Health Corp and gave the stock a “buy” rating in a research note on Sunday, December 18th. Vetr downgraded shares of CVS Health Corp from a “strong-buy” rating to a “buy” rating and set a $86.51 price objective for the company. in a research note on Thursday, December 8th. Guggenheim reissued a “buy” rating and issued a $90.00 price objective on shares of CVS Health Corp in a research note on Wednesday, December 28th. Finally, Credit Suisse Group AG reissued a “buy” rating on shares of CVS Health Corp in a research note on Monday, December 19th. Eight analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. CVS Health Corp currently has an average rating of “Buy” and a consensus price target of $95.99.
CVS Health Corp Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.